Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells.
Rouleau
M
M
Laboratoire d'Immunologie Cellulaire et de Transplantation, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
Bernard
A
A
Lantz
O
O
Vernant
J P
JP
Charpentier
B
B
Senik
A
A
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D017209:Apoptosis / Q000276:immunology*; D018801:CD2 Antigens / Q000276:immunology*; D017252:CD3 Complex / Q000276:immunology; D018959:CD57 Antigens; D016827:CD8 Antigens / Q000276:immunology*; D002478:Cells, Cultured; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D017252:CD3 Complex; D018959:CD57 Antigens; D016827:CD8 Antigens; D007376:Interleukin-2